Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent Asthma as compared with fluticasone propionate in a randomized open double-cross study

Allergology International

Volumn 57, Issue 3, 2008, Pages 231-239

  Ohbayashi, Hiroyuki ^a,b   Adachi, Mitsuru ^b  

^a JA Gifu Tohno Kousei Hospital   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; DISKUS; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE PROPIONATE; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ADULT; AGED; AIRWAY EOSINOPHILIC INFLAMMATION; ARTICLE; ASTHMA; ASTHMA RELATED QUALITY OF LIFE QUESTIONNAIRE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG EFFICACY; EOSINOPHIL COUNT; EVIDENCE BASED MEDICINE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; MALE; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPUTUM CYTODIAGNOSIS; SYMPTOM; VITAL CAPACITY;

EID: 53749105516     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-07-522     Document Type: Article

References (18)

1. Hamid Q, Song Y, Kotsimbos TC et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100:44-51.
2. Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 2002;109:S 447-60.
3. Ohbayashi H. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation]. Arelugi [Jpn J Allergol] 2005;54:24-35(in Japanese).
4. Ohbayasbi H. One-year evaluation of the preventative effect of Hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration 2006; 73:146-53.
5. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12:1346-53.
6. Ederle K, Multicentre Study Group. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study. Eur Rev Med Pharmacol Sci 2003;7:45-55.
7. National Institutes of Health, National Heart, Lung, and Blood Institute, Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2002;102-14.
8. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999;115:1265-70.
9. Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate. Br J Clin Pharmacol 2001;52:93-5.
10. Aubier M, Wettenger R, Gans SJ. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day (-1)) versus HFA-fluticasone propionate (1000 microg day (-1)) in patients with asthma. Respir Med 2001; 95:212-20.
11. Leach CI, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 2002; 122:510-6.
12. Hauber H, Taha R, Bergeron C, Miqounov V, Hamid Q, Olivenstein R. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients. Can Respir J 2006;13: 73-8.
13. Van Aalderen WM, Price D, De Baets FM, Price J. Beclomethasone dipropionate extra-fine aerosol versus fluticasone propionate in children with asthma. Respir Med 2007;101:1585-93.
14. Lasserson TJ, Cates CK, Jones AB, Steele EH, White J. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children. Cochrane Database Syst Rev 2006;2:CD005309.
15. Fairfax A, Hall I, Spelman R. A randomized, double-blind comparison of beclomethasone dipropionate extra-fine aerosol and fluticasone propionate. Ann Allergy Asthma Immunol 2001;86:575-82.
16. Fahy JV, Wong H, Liu J, Boushey HA. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med 1995;152:53-8.
17. Gershman NH, Liu H, Wong HH, Liu JT, Fahy JV. Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol 1999;104:322-8.
18. Mason RJ. Biology of alveolar type II cells. Respirology 2006; 11:S12-5.